Cargando…
Therapeutic applications of radioactive (131)iodine: Procedures and incidents with capsules
BACKGROUND: Treatments for thyrotoxicosis and carcinoma thyroid are carried out by oral administration of radioactive iodine ((131)I) in the form of liquid or capsules. The liquid form of (131)I has higher risk factors such as vapourization, spillage and need for management of higher activity wastes...
Autores principales: | Al Aamri, Marwa, Ravichandran, Ramamoorthy, Binukumar, John Pichy, Al Balushi, Naima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918478/ https://www.ncbi.nlm.nih.gov/pubmed/27385885 http://dx.doi.org/10.4103/0972-3919.183603 |
Ejemplares similares
-
Radioactive iodine (I-131) therapy isolation rooms: Introduction of lead glass window on the wall for patient comfort and better ambience
por: Al Aamri, Marwa, et al.
Publicado: (2019) -
Radioactive Body Burden Measurements in (131)Iodine Therapy for Differentiated Thyroid Cancer: Effect of Recombinant Thyroid Stimulating Hormone in Whole Body (131)Iodine Clearance
por: Ravichandran, Ramamoorthy, et al.
Publicado: (2014) -
Radioactive (131)Iodine Body Burden and Blood Dose Estimates in Treatment for Differentiated Thyroid Cancer by External Probe Counting
por: Ravichandran, Ramamoorthy, et al.
Publicado: (2016) -
Regarding Care Giving Family Members Stray Radiation Exposures from Discharged Patients after Administration of Large Dose Therapeutic Radioactive Iodine in Differentiated Carcinoma Thyroid
por: Ravichandran, Ramamoorthy, et al.
Publicado: (2022) -
Estimation of effective half life of clearance of radioactive Iodine ((131)I) in patients treated for hyperthyroidism and carcinoma thyroid
por: Ravichandran, R, et al.
Publicado: (2010)